Matuzumab Completed Phase 2 Trials for Esophageal Cancers / Malignant Neoplasm of Stomach Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00215644Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric Cancer